Sung Keun Park

Sung Keun Park

Auto-generated profile, based on publicly available information

Sung Keun Park

Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2014 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
JRJae‐Hong Ryoo
Jae‐Hong Ryoo
YSYoung Ju Suh
Young Ju Suh
HSHo Cheol Shin
Ho Cheol Shin
YCYong Kyun Cho
Yong Kyun Cho
JCJoong‐Myung Choi
Joong‐Myung Choi
SPSung Keun Park
Sung Keun Park

1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
JJJu Young Jung
Ju Young Jung
SPSung Keun Park
Sung Keun Park
COChang-Mo Oh
Chang-Mo Oh
PCPil-Wook Chung
Pil-Wook Chung
JRJae-Hong Ryoo
Jae-Hong Ryoo
Recent studies have indicated the significant association between non-alcoholic fatty liver disease (NAFLD) and depression. However, there is ongoing debate on whether the risk for depression is actually related with the presence and severity of NAFLD. Thus, this study was conducted to investigate the association between depression and NAFLD evaluated by diverse modalities. A total of 112,797 participants from the Korean general population were enrolled. The study participants were categorized into three groups according to degree of NAFLD evaluated by ultrasonography, fatty liver index (FLI) and fibrosis-4 score (FIB-4). Depression was defined as a score of Center for Epidemiological Studies-Depression (CES-D) ≥ 16, and the odd ratios (ORs) and 95% confidence interval (CI) for depression (adjusted ORs [95% CI]) were assessed by multiple logistic regression analyses. In the unadjusted model, the presence and severity of NAFLD was not significantly associated with depressive symptoms. However, in the fully adjusted model, ORs for depression increased in proportion to the degree of ultrasonographically detected NAFLD (mild fatty liver: 1.14 [1.06-1.22]; and moderate to severe fatty liver: 1.32 [1.17-1.48]). An association was also observed between depression and FLI (30 ≤ FLI < 60: 1.06 [0.98-1.15]; FLI ≥ 60: 1.15 [1.02-1.29]). The presence and severity of NAFLD is significantly associated with depressive symptoms. In addition, this association was more distinct after adjusting for covariates including age, gender and insulin resistance. This finding indicates the necessity of further study evaluating the incidental relationship of depression with NAFLD.

1 April 2019 in Atherosclerosis
Verified
Journal Article
Open access
IOIn-Hwan Oh
In-Hwan Oh
JHJunho K. Hur
Junho K. Hur
JRJae-Hong Ryoo
Jae-Hong Ryoo
JJJu Young Jung
Ju Young Jung
SPSung Keun Park
Sung Keun Park
COChang-Mo Oh
Chang-Mo Oh
Our study aimed to investigate the association between high-density lipoprotein cholesterol (HDL-C) and all-cause and cause-specific mortality in Korean adults. A total of 365,457 participants aged ≥40 years were selected from the Korean National Health Insurance Service-National Sample Cohort from 2009 to 2015. HDL-C level was categorized into <1.0, 1.0-1.19, 1.2-1.39, 1.4-1.59, 1.6-1.79 (reference), 1.8-1.99, 2.0-2.19 and ≥ 2.20 mmol/L. Cox proportional hazard models were used to examine the association between HDL-C level and mortality risk. In a median 3.5-year follow-up period, 9,350 participants (2.6%) died. Men with HDL-C level of 1.6-1.79 mmol/L and women with HDL-C level of 1.4-1.59 mmol/L had the lowest age-standardized mortality rates for all-cause death. However, for cardiovascular death, men with HDL-C level ≥2.20 mmol/L and women with HDL-C level of 1.8-1.99 mmol/L showed the lowest mortality rate. After adjusting for multiple covariates, the hazard ratios for all-cause and cancer deaths showed a U-shaped relationship with HDL-C level for both sexes. However, there were heterogenetic associations between HDL-C level and mortality risk of subtypes of cardiovascular disease by sex. For other causes of death except for cardiovascular and cancer death, elevated mortality risk was mainly due to external causes (ICD-10 code, S00-T98). In South Korea, very high HDL-C level was associated with increased risk of all-cause death. However, the increased all-cause mortality risk in people with very high HDL-C level was partly due to mortality risk from external causes.

3 February 2020 in Cancer
Verified
Journal Article
Open access
PDF file
SPSung Keun Park
Sung Keun Park
COChang-Mo Oh
Chang-Mo Oh
MKMin-ho Kim
Min-ho Kim
EHEunhee Ha
Eunhee Ha
YCYong Sung Choi
Yong Sung Choi
JRJae-Hong Ryoo
Jae-Hong Ryoo
Background: Components of the metabolic syndrome (MetS), such as elevated fasting glucose levels and abdominal obesity, have been suggested as potential risk factors for pancreatic cancer. However, data are still insufficient to assure the influence of MetS on incident pancreatic cancer. The objective of the current study was to investigate the association between MetS, metabolic components, and the risk of pancreatic cancer. Methods: In the Korea National Health Information Database, 223,138 individuals who were without pancreatic cancer in 2009 were enrolled and followed until 2013. They were categorized into 4 groups according to the number of baseline metabolic components (0, 1, 2, 3, and 4‐5). A multivariate Cox proportional hazard model was used to calculate the adjusted hazard ratios (HRs) and 95% CIs for incident pancreatic cancer according to the presence of MetS and the number of metabolic components. In addition, the risk of pancreatic cancer was evaluated in individuals who had a single metabolic component. Results: The presence of MetS was significantly associated with incident pancreatic cancer (adjusted HR, 1.47; 95% CI, 1.19‐1.81). The group with 4 or 5 baseline metabolic components had a higher risk of pancreatic cancer than the other groups (0 components: reference category; 1 component: adjusted HR, 0.94 [95% CI, 0.61‐1.45]; 2 components: adjusted HR, 1.03 [95% CI, 0.68‐1.56]; 3 components: adjusted HR, 1.35 [95% CI, 0.89‐2.04]; 4‐5 components: adjusted HR, 1.64 [95% CI, 1.06‐2.51]). Regarding associations between the individual metabolic components and pancreatic cancer, no metabolic component alone had a statistically significant association with pancreatic cancer. Conclusions: MetS is a potential risk factor for pancreatic cancer. The presence of ≥4 metabolic components leads to a higher risk of pancreatic cancer even within categories of the MetS.

1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JRJae-Hong Ryoo
Jae-Hong Ryoo
WHWoo Taek Ham
Woo Taek Ham
JCJoong-Myung Choi
Joong-Myung Choi
MKMin A Kang
Min A Kang
SASo Hee An
So Hee An
SPSung Keun Park
Sung Keun Park
Ryoo JH, et al. J Korean Med Sci. 2014 Jul;29(7):973-979. http://dx.doi.org/10.3346/jkms.2014.29.7.973

1 March 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
JRJae-Hong Ryoo
Jae-Hong Ryoo
SKSun Yong Kim
Sun Yong Kim
COChang-Mo Oh
Chang-Mo Oh
SPSung Keun Park
Sung Keun Park
EKEugene Kim
Eugene Kim
TKTaeg Su Ko
Taeg Su Ko